Dr. Bhanushali is a board-certified neurologist, currently seeing patients in the Palo Alto and San Carlos locations within Sutter. She also serves as our Medical Director at the Research Institute in Palo Alto. After finishing medical school, Dr. Bhanushali started working as a research associate in the Neurology department at University of Minnesota and was involved in various clinical trials for Parkinson’s disease. This perked her interest in the rapidly growing and evolving field of Neurology and hence, pursued a Neurology residency at Detroit Medical Center, followed by fellowship in Neuromuscular and Clinical Neurophysiology at Emory University. Dr. Bhanushali has a wide breath of experience working at various institutions including Michigan State University, where in addition to practicing general neurology she directed the Muscular Dystrophy Association (MDA) clinic, and at Kaiser Permanente Medical center in Oakland where she was Medical Director of the Stroke program. Additionally, she worked as a Neurohospitalist and telestroke consultant at Providence Sacred Heart Medical Center in Washington.
Sutter Health Research Enterprise
795 El Camino Real
Palo Alto, CA, 94301
(650) 853-2983
BhanusM@pamf.org
Primary Research Interests
Related Clinical Trials
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 over 52 Weeks in Participants with Early Alzheimer’s Disease
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants with Early Alzheimer’s Disease
Investigators: Brajesh Agrawal MD, Minal Bhanushali MD, PAMFRI Medical Director
Status: Active, Recruiting
A phase III multicenter, randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with ocrelizumab in adult patients with PPMS
Multiple sclerosis study to evaluate effectiveness and safety of fenebrutinib
Investigators: Minal Bhanushali MD, PAMFRI Medical Director, David Gershfield MD, Ariele L Greenfield M.D., Director of PAMF Multiple Sclerosis Center, Neurologist and Researcher, Christine Hessler MD
Status: Active, Not Recruiting
ARTIOS
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Dimethyl Fumarate or Fingolimod to Ofatumumab
Investigators: Minal Bhanushali MD, PAMFRI Medical Director, Ariele L Greenfield M.D., Director of PAMF Multiple Sclerosis Center, Neurologist and Researcher
Status: Completed
New IDEAS: Imaging Dementia—Evidence for Amyloid Scanning Study
A Study to Improve Precision in Amyloid PET Coverage and Patient Care
Investigators: Brajesh Agrawal MD, Minal Bhanushali MD, PAMFRI Medical Director, David Eric Collins MD
Status: Completed